Holen Sie sich die Stockscreener-App
95.50
3.83%
3.52
Handel nachbörslich:
95.50
Biontech Se Adr Aktie (BNTX) Neueste Nachrichten
BioNTech SE Sponsored ADR Revenue Breakdown – BSESOF:22UA - TradingView
BioNTech Earnings Call: Cash-Rich Pivot Beyond COVID - TipRanks
Operating income of BioNTech SE Sponsored ADR – BSESOF:22UA - TradingView
BioNTech's Shareholder Vote to Cement Post-Pandemic Strategy () - aktiencheck.de
Why Is Pfizer Stock Dropping Tuesday? - Sahm
European ADRs Slipped As Biotech Lagged And UK Names Rose - Finimize
BNTX Stock Price, Quote & Chart | BIONTECH SE-ADR (NASDAQ:BNTX) - ChartMill
BioNTech's Strategic Pivot: Fueling Oncology Ambition with Capital Reserves () - aktiencheck.de
BioNTech Shares Navigate Dual Challenges Amid Strategic Shift () - aktiencheck.de
BioNTech announces invitation to 2026 annual general meeting for May 15 - Investing.com
BioNTech's mRNA Vaccine Platform: Current Developments and Strategic Importance for North American I - AD HOC NEWS
HC Wainwright Issues Negative Estimate for BioNTech Earnings - MarketBeat
BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at HC Wainwright - Defense World
BioNTech SE (STU:22UA) Stock Price, Trades & News - GuruFocus
BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know - MSN
BNTX Stock Today: March 31: ELCC Cancer Data Steady Amid Biotech Rout - Meyka
BioNTech at a Crossroads: Financial Pressures and Clinical Promise Collide () - aktiencheck.de
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Short Interest Down 20.7% in March - MarketBeat
BioNTech's Oncology Pipeline Shows Promise with Significant Survival Data () - aktiencheck.de
BioNTech SE Sponsored ADR Trade Ideas — BSESOF:22UA - TradingView
Total equity of BioNTech SE Sponsored ADR – BSESOF:22UA - TradingView
ETFs Investing in BioNTech SE Sponsored ADR Stocks - TradingView
EBITDA per share of BioNTech SE Sponsored ADR – BSESOF:22UA - TradingView
BioNTech’s Mpox Vaccine Study Reaches Completion: What Investors Should Watch Next - TipRanks
BioNTech SE Sponsored ADR $BNTX Shares Bought by SG Americas Securities LLC - MarketBeat
BioNTech (NASDAQ:BNTX) Receives Buy Rating from Jefferies Financial Group - defenseworld.net
BioNTech stock plunges as founders leave. Should you buy the dip in BNTX here? - MSN
BioNTech Oncology Pipeline Shows Promising Survival Data in Late-Stage Lung Cancer Trials as of Marc - AD HOC NEWS
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer - GlobeNewswire Inc.
AKT I: „ICI VARSOVIE” [c66293] - Fathom Journal
BioNTech Faces Leadership Transition Amid Pivotal Clinical Milestones () - aktiencheck.de
BioNTech's Oncology Pivot Accelerates Amid Leadership Transition and €17B Cash Reserve - AD HOC NEWS
Hudson Bay Capital Management LP Acquires 55,004 Shares of BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech Stock Forecast | Co-Founders Plan Departure - Capital.com
Groupama Asset Managment Trims Holdings in BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech (NASDAQ:BNTX) Given “Buy” Rating at Deutsche Bank Aktiengesellschaft - Defense World
Long Focus Capital Management LLC Has $39.22 Million Stock Holdings in BioNTech SE Sponsored ADR $BNTX - MarketBeat
BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
BioNTech a Takeover Target? What's Happening at CHAR Technologies and Steyr Motors? - news.financial
symbol__ Stock Quote Price and Forecast - CNN
125,000 Shares in BioNTech SE Sponsored ADR $BNTX Purchased by Ghisallo Capital Management LLC - MarketBeat
BioNTech SE Sponsored ADR $BNTX Shares Acquired by Dodge & Cox - MarketBeat
BioNTech SE Stock (ISIN: US09075V1026) Faces Pressure After Leadership Exodus and Earnings Miss - AD HOC NEWS
BNP Paribas Financial Markets Lowers Stock Holdings in BioNTech SE Sponsored ADR $BNTX - MarketBeat
BNTX Stock Today: Founders to Exit; PT Cut to $167 – March 12 - Meyka
BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development - Morningstar
BioNTech (NASDAQ:BNTX) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Serve Robotics Posts Upbeat Q4 Results, Joins Auna, Acacia Research And Other Big Stocks Moving Higher On Wednesday - Benzinga
BMO cuts BioNTech stock price target on CEO departure plans - Investing.com
BioNTech SE Sponsored ADR $BNTX Shares Sold by Capital International Inc. CA - MarketBeat
BioNTech tumbles over 19% on fourth quarter earnings miss - Investing.com
Oppenheimer maintains BioNTech stock rating amid leadership exit - Investing.com
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):